Director of Discovery ADME Services
Q Squared Solutions
Indianapolis, Indiana
Senior Director, Site Lead & Discovery ADME Services
Lead for multidisciplinary team of 100+ people that supports in vitro drug screening, in vivo pharmacokinetics, bioanalysis (GLP/non GLP), Met ID Biotransformation, in Vitro Metabolism, Ligand Binding Assays and Large Molecule BioA.
Prior to joining the Q2 Solutions, served as Principal Investigator and Senior Bioanalytical Scientist at Inotiv
Multiple roles as sub-functional leader at Dow responsible for new product development and led bioanalytical group that supported R&D, regulatory and Manufacturing units
University of Utah, conducted similar studies to support clinical trials and nutritional interventions and developed and validated methods for protein interactions, determined MOA. Identified 2 new proteins from Human Retina.
Published over 35 peer-reviewed articles, 3 patent applications and a book chapter.
Disclosure information not submitted.
High Resolution Accurate Mass Analysis: Addressing Sensitivity and Specificity
Tuesday, May 14, 2024
10:15 AM – 11:00 AM PT